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Abstract The purpose of this study was to perform an anal-
ysis of Streptococcus suis human invasive isolates, collected
in Poland by the National Reference Centre for Bacterial
Meningitis. Isolates obtained from 21 patients during 2000–
2013 were investigated by phenotypic tests, multilocus se-
quence typing (MLST), analysis of the TR9 locus from the
multilocus variable number tandem repeat (VNTR) analysis
(MLVA) scheme and pulsed-field gel electrophoresis (PFGE)
of SmaI-digested DNA. Determinants of virulence and anti-
microbial resistance were detected by polymerase chain reac-
tion (PCR) and analysed by sequencing. All isolates represent-
ed sequence type 1 (ST1) and were suggested to be serotype 2.
PFGE and analysis of the TR9 locus allowed the discrimina-
tion of four and 17 types, respectively. Most of the isolates
were haemolysis- and DNase-positive, and around half of
them formed biofilm. Genes encoding suilysin, extracellular
protein factor, fibronectin-binding protein, muramidase-
released protein, surface antigen one, enolase, serum opacity
factor and pili were ubiquitous in the studied group, while
none of the isolates carried sequences characteristic for the
89K pathogenicity island. All isolates were susceptible to pen-
icillin, cefotaxime, imipenem, moxifloxacin, chlorampheni-
col, rifampicin, gentamicin, linezolid, vancomycin and dapto-
mycin. Five isolates (24 %) were concomitantly
non-susceptible to erythromycin, clindamycin and tetracy-
cline, and harboured the tet(O) and erm(B) genes; for one
isolate, lsa(E) and lnu(B) were additionally detected.
Streptococcus suis isolated in Poland from human invasive
infections belongs to a globally distributed clonal complex
of this pathogen, enriched in virulence markers. This is the
first report of the lsa(E) and lnu(B) resistance genes in S. suis.
Introduction
Streptococcus suis represents one of most important patho-
gens of pigs, responsible for septicaemia, meningitis, arthritis
and pneumonia in newborn and young animals of this species
[1]. These bacteria are also a cause of invasive diseases in
humans, mainly meningitis, as well as septicaemia, endocar-
ditis and arthritis [2]. Such infections are typically sporadic,
and, in the majority of cases, occur in particular occupational
groups, such as abattoir workers and butchers. Infection may
also be acquired by contact with raw or undercooked meat
products, traditionally consumed in the Far East of Asia [2]
and, thus, S. suis should be considered a food-borne pathogen
[3]. In some countries of this region, such as Vietnam, S. suis
represents the most frequent cause of bacterial meningitis in
adults [4]. Streptococcus suis of serotype 2 (SS2) is consid-
ered the most virulent in both humans and animals among the
currently recognised 29 serotypes [2, 5]. Tonsil carriage of
SS2 by healthy slaughterhouse pigs represents an important
natural reservoir of this pathogen [6]. Other serotypes, sporad-
ically isolated from humans, include 1, 4, 5, 14, 16, 21 and 24
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[2]. The threat posed by S. suis to public health was further
emphasised with reports of two outbreaks in China in 1998
and 2005, involving 25 and 215 patients, and 14 and 38
deaths, respectively [7]. Streptococcal toxic shock syndrome
(STSS) and high mortality of patients, observed in both out-
breaks, was attributed to the presence of the 89K putative
pathogenicity island (89K PAI) found in strains responsible
for these outbreaks [8]. Further studies identified genes
encoding a two-component signal transduction system
SalK/SalR, a type IV-like secretion system and a novel
haemolysis-related gene hhly3, located within this element
and presumably involved in the STSS development [9–11].
While S. suis shows quite significant variability of the general
population structure, as revealed by e.g. multilocus sequence
typing (MLST), human isolates belong almost exclusively to a
single clonal complex (CC), CC1, with a central and likely
ancestral sequence type 1 (ST1) associated with serotype 2
[12]. The most widely studied virulence-associated factors of
S. suis include suilysin (Sly), extracellular factor (EF),
fibronectin-binding protein (FBP), muramidase-released protein
(MRP), surface antigen one (Sao), enolase (Eno), DNase
(SsnA), serum opacity factor (OFS), pili and others [13–17].
Human isolates of S. suis retain susceptibility to penicillin, cef-
triaxone and vancomycin, but are frequently resistant to tetracy-
cline and erythromycin, e.g. a study in Vietnam showed preva-
lence rates of resistance to these compounds as high as 83% and
20 %, respectively [4]. Integrative conjugative elements (ICE)
seem to play an important role in the transmission of resistance
determinants to this species, as demonstrated by genomic studies
[18]. Plasmids are observed in S. suis as well [18, 19], but their
role in resistance development remains as yet little studied.
Moreover, a recent study [20] has shown that S. suis is capable
of developing competence for DNA uptake in a process depen-
dent on the comR and comX gene products, thus providing an-
other possibility for the acquisition of resistance determinants.
Recently, a meningitis case due to S. suis was reported in
Poland [21]. The diversity of S. suis strains involved in inva-
sive human infections in our country, as well as their relation-
ships to strains from Europe and other continents, remain un-
known up to now. Therefore, we aimed at performing a de-
tailed analysis of isolates, collected by the National Reference
Centre for Bacterial Meningitis (NRCBM) located at the
NationalMedicines Institute, in the respect of their phenotypic
and genotypic features.
Materials and methods
Bacterial isolates and patient data
The NRCBM started its activity in 1997, and the first S. suis
isolate from a human invasive infection was received in 2000.
Between then and the end of 2013, 21 cases of invasive
infection caused by S. suis (20 cases of meningitis and one
case of endocarditis) were reported to the NRCBM from 13
hospitals located throughout Poland (Table 1). Seventeen
(81 %) patients were male; the age ranged from 28 to 67 years
(average, 50 years). Overall, 19 isolates were obtained from
cerebrospinal fluid (CSF) and seven isolates were from blood.
For five patients, isolates were received from both blood and
CSF, but only one isolate from each patient was included in
the analysis. Upon receipt, all isolates were re-identified using
the Rapid ID32 STREP or the VITEK II GP system (both
from bioMérieux, Marcy l’Etoile, France) and stored at
−80 °C.
Phenotypic studies
Antimicrobial susceptibility was tested using the broth
microdilution method [22] for penicillin, cefotaxime,
imipenem, erythromycin, moxifloxacin, tetracycline, chlor-
amphenicol, rifampicin, gentamicin, linezolid and vancomy-
cin; susceptibility to daptomycin was studied by the Etest
method (bioMérieux, Marcy l’Etoile, France) and susceptibil-
ity to clindamycin by the disk diffusion method [22].
Streptococcus pneumoniae ATCC 46916 strain was used for
quality control purposes. The results were interpreted follow-
ing the breakpoints for viridans streptococci approved by the
European Committee on Antimicrobial Susceptibility Testing
(EUCAST) for penicil l in, cefotaxime, imipenem,
clindamycin, gentamicin and vancomycin, and the Clinical
and Laboratory Standards Institute (CLSI) for of erythromy-
cin, tetracycline, chloramphenicol, linezolid and daptomycin
[22, 23]. In the case of moxifloxacin and rifampicin,
S. pneumoniae breakpoints were used [23]. Haemolysis was
evaluated visually as a distinct zone around bacterial colonies
on Columbia agar with 5 % horse blood (bioMérieux, Marcy
l’Etoile, France). The ability of isolates to form biofilm was
evaluated in microtitre plates in BHI liquid medium with
0.5 % glucose and with or without 2.5 mg/ml of human plas-
ma fibrinogen (Sigma-Aldrich, St. Louis, MO, USA), follow-
ed by staining with crystal violet, as previously described [24].
A biofilm-forming clinical isolate of Enterococcus faecalis
from our collection was used as a positive control. The exper-
iment was performed in triplicate and isolates with a mean
OD550≥0.12 were considered positive in the test. DNase ac-
tivity [17] was tested by direct visual evaluation on DNase
agar with Methyl Green (Becton Dickinson, Sparks, MD,
USA), using Staphylococcus aureus ATCC 25923 as a posi-
tive control.
DNA isolation and bacterial typing
Total DNAwas purified using the Genomic DNA Prep Plus
kit following the manufacturer’s instructions (A&A
Biotechnology, Gdynia, Poland). MLST was performed as
previously described [12]; allele numbers and sequence
types (STs) were assigned using the MLST database
http://ssuis.mlst.net/ (accessed 17th December 2015).
Pulsed-field gel electrophoresis (PFGE) analysis of SmaI-
digested DNA was performed following the standard pro-
cedure [25]. The number of variable number tandem repeats
(VNTR) (5′GAGCA)n in the TR9 locus included in the
proposed multilocus VNTR analysis (MLVA) scheme [26]
was established using polymerase chain reaction (PCR)
amplification of TR9 and sequencing of the products.
Serotype of isolates was determined using primers specific
for the cps loci of serotypes 2 and 1/2 [27].
Analysis of virulence determinants
The fbpS, epf, eno and sly genes were detected as described by
others [27–30]. The presence of orfC was investigated by
PCR with primers 5′-AGATTGGGATGAACTGGTCG and
5′-AATAGCCGTATGACCTGCCA, specific for orfB and
orfC, respectively (GenBank accession number AJ416308
[30]). The 89K PAI sequences were searched using primers
CH3 and CH4, specific for unique sequences within the PAI
[31]. Additionally, PCR with primers CH1 and CH6 [31],
targeting sequences adjacent to this PAI, was used to exclude
its presence in isolates negative in the previous reaction. The
ofs and sao types were investigated as described [16, 32]. The
pili genotypes were established using the published scheme
employing primers specific for four pili gene clusters [15],
including the sequencing of sbp2. The region encompassing
1–2286 bp inmrpwas analysed by sequencing of the products
of overlapping PCR [33], and the number of repeats in the
repeat region by sizing of PCR products containing this region
[34].
Detection of antimicrobial resistance, transposon
and plasmid genes
Tetracycline resistance genes tet(M), tet(O), tet(L), tet(K), tet
(W), macrolide resistance genes erm(B), mef(A) and intTn916
were detected by PCR as described by others [35–38]. For the
detection of tet(40) and the lincosamide resistance genes lsa
(E) and lnu(B) , p r imer pa i r s t e t40-up / t e t40-dn
( 5 ′ - C TA C C T G C T G T T C C G AT T T G T C a n d
5′-TGATGAAGGTATCACCGCAACC), lsaE-up/lsaE-dn
( 5 ′ - TAT GCG TAT T C CGGCAATATAAG a n d
5′-AACGGCTTCCTGATGTCTTG) and lnuB-up/lnuB-dn
( 5 ′ - C G TGGGGAAT T TCAT T T CC T T T C a n d
5′-CGTTGATTCCCATCAACCATAG) were used, respec-
tively. The linkage between genes lsaE-lnuB and ermB-tetO
was investigated with primers lsaE-up/lnuB-dn and ermB-1/
tetO-dn [36, 38], respectively. The presence of rep1 and rep2
genes, characteristic for broad-host range streptococcal and
enterococcal plasmids, was tested using primers and
conditions proposed in the Gram(+) plasmid typing scheme
[39]. The reppBM407 gene [18] was searched by PCR with
primers rep407-up/rep407-dn (5′-GTATCGCACGTA
TTCCTCGTG and 5′-CATAATAGCCTTTTCCCCACGA).
Theω-ε-ζ and relBE genes of plasmid toxin–antitoxin systems
(TAS) were searched for as previously described [40]. The
repA gene, specific for ICESsuSC84 and ICESsuBM407-2 [18],
was detected with consensus primers repA_up/repA_dn
(5′-TTAAGGTAGCCTACGCGGTTTTA and 5′-GTC
GTCTCAGTTGCTTRGTCC). DNA from previously
characterised clinical isolates of Streptococcus agalactiae,
E. faecalis andEnterococcus faecium from our collectionwere
used as positive controls for the detection of tet(M), tet(O), tet
(L), tet(K), tet(W), erm(B),mef(A), intTn916, rep1, rep2,ω-ε-ζ and
relBE. Competence-associated genes comX and comR were de-
tected with primer pairs comX-up/comX-dn and comR-up/
c omR -d n ( 5 ′ -GGATCGAGATGATTGGGAAC /
5′-CATGTGGCATACGGTCAAAC and 5′-CTGAAGTT
TGATGTGCTTCGC/5′-TTTCCAAAGCCTGCTGTACCT,
respectively).
DNA sequence analysis
Sequences were analysed using the Lasergene package
(DNASTAR, Madison, WI, USA). New sequences found in
this study were submitted to the GenBank: sao (KJ739797),
mrp (KJ776426, KJ776427, KJ746998, KJ746999),
ISSag3-like (KR137531).
Results
Serotypes and clonality of isolates
PCR and MLST analyses demonstrated that all isolates were
positive for serotypes 2- and 1/2-specific PCR and belonged
to ST1. Because no human infection due to serotype 1/2
strains has yet been reported in any country [41], the PCR
results strongly suggest that all the isolates are serotype 2.
PFGE analysis identified four related patterns, A1–A4
(Table 1 and Supplementary Fig. 1). The predominant pattern,
A1, was characteristic of 18 isolates. Sequencing of the TR9
locus from the MLVA scheme revealed 17 variants, with 8–72
repeats.
Virulence phenotypes and determinants
Ten isolates (48 %) were able to form biofilm in the medium
supplemented with fibrinogen (Table 1); no biofilm was ob-
served in the absence of this compound. Fifteen isolates
(71%) showed variable levels of DNase activity.With a single
exception, all isolates caused various degrees ofβ-haemolysis
of horse blood and harboured the sly gene. This single isolate
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was negative in PCR for both sly and orfC. None of the iso-
lates harboured sequences characteristic for the 89K PAI, and
all isolates yielded expected ∼1.5 kb PCR product with
primers specific for sequences located upstream and down-
stream of the PAI, further confirming its absence. All isolates
carried the fbpS, eno, epf, sao, mrp and pili genes. The size of
the PCR product for epf corresponded to the basic variant of
this gene without insertions in the 3′ part [28]. The sao gene
represented the M-type (i.e. with seven repeats) [32], with the
exception of one isolate, which had six repeats. Analysis of
the 3′ part of the mrp gene by PCR showed the presence of a
single repeat for the majority (19) of isolates; one isolate had
the mrpS variant [34] and one had a novel mrp variant, con-
taining a 162-bp deletion in the repeat region, encompassing
nt4898–5059. Partial sequencing of the variable region ofmrp
revealed the presence of two new mutations, both resulting in
a translational frameshift, a two-nucleotide insertion at posi-
tion 571 in two isolates and a single-nucleotide deletion at
position 1699 in one case. For the remaining isolates, the
sequence was 100 % identical with the European variant
(GenBank accession number X64450) of mrp [33]. Analysis
of the pili gene clusters showed that all isolates belonged to
genotype A, i.e. they were positive for the srtBCD cluster, the
srtE/sipE genes and the srtF cluster. All isolates contained a
Table 1 Selected features of human invasive isolates of Streptococcus suis isolated in Poland from 2000 to 2013
Year Citya Isolation
materialb
Antibiotic
resistance
profile c
PFGE TR9d Haemolysis/
sly genee,f
Biofilm
formationf
DNase
activityf,g
OFS
type
sao
type
mrp,
repeat
region
mrp,
variable
5′
regionh
ω-
ε-ζf
repA of
ICESsuSC84
ICESsuBM
407-2
2000 Gdańsk CSF S A1 36 +++/+ neg + 1 M mrp wt neg neg
2003 Gdańsk CSF S A1 14 +++/+ pos neg 1 M mrp wt neg neg
2004 Opole CSF/blood S A1 35 ++/+ neg neg 1 M mrp wt neg neg
2004 Opole CSF S A4 8 ++/+ pos + 1 M mrp wt neg neg
2005 Elbląg CSF/blood S A1 35 ++/+ pos ++ 1 M mrp wt neg neg
2005 Kędzierzyn-
Koźle
CSF S A1 42 ++/+ neg neg 1 M mrp wt neg neg
2006 Nowa Sól bloodx S A1 33 ++/+ neg + 1 M mrp wt neg neg
2007 Pleszew CSF/blood ECT A1 15 ++/+ pos neg 1 6
re-
pe-
ats
mrp Δ1699 neg pos
2008 Gdańsk CSF/blood S A1 28 neg/neg pos + 1 M mrp ins 571′ neg neg
2009 Olsztyn CSF S A1 15 ++/+ neg neg 1 M mrpS wt neg neg
2010 Brzeg bloody S A1 32 ++/+ neg ++ 1 M mrp wt neg neg
2010 Bełchatów CSF S A1 34 ++/+ neg neg 1 M mrp wt neg neg
2010 Puławy CSF ECT A3 19 ++/+ neg + 1 M mrp wt pos pos
2010 Koszalin CSF ECT A1 26 ++/+ pos + ISSag3 M mrp wt neg pos
2011 Koszalin CSF/blood ECT A2 72 +/+ pos + 1 M mrp wt neg pos
2011 Chojnice CSF S A1 29 ++/+ pos ++ 1 M mrp wt neg neg
2012 Elbląg CSF S A1 26 ++/+ pos ++ 1 M mrp wt neg neg
2012 Wejherowo CSF S A1 29 ++/+ neg ++ 1 M mrp wt neg neg
2013 Chojnice CSF S A1 39 +/+ neg ++ 1 M mrp ins 571′ neg neg
2013 Koszalin CSF ECT A1 61 ++/+ neg + 1 M Δ162 bp wt neg pos
2013 Opole CSF S A1 23 +++/+ pos + 1 M mrp wt neg neg
a City of patient hospitalization
b For five patients, two isolates were obtained (from CSF and blood), and both isolates shared all features tested
c S, susceptible to all antimicrobials tested; ECT, resistance to erythromycin, clindamycin and tetracycline (isolate harbouring the lsa(E)/lnu(B) genes
underlined
d TR9, number of repeats in the TR9 locus from the MLVA scheme
e +, ++, +++, weak, intermediate and strong haemolysis, respectively
f pos, positive; neg, negative
g +, ++, weak and strong DNAse activity, respectively
hwt, wild-type sequence
x Patient diagnosed with endocarditis
y Patient diagnosed with meningitis
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single T insertion at position 798′ of the sbp2 gene, which split
the sbp2 open reading frame (ORF) into sbp2′ and sbp2″ [15].
All isolates carried the type 1 ofs gene, with the exception of
one isolate, for which partial sequencing revealed the presence
of the ISSag3-like insertion sequence from S. agalactiae [42]
(97 % identity at the nucleotide level) at nt1165, in the same
orientation as the ofs gene.
Antimicrobial susceptibility profiles of isolates, resistance
and competence determinants
All isolates were susceptible to penicillin, cefotaxime,
imipenem, moxifloxacin, chloramphenicol, rifampicin, genta-
micin, linezolid, vancomycin and daptomycin. Five isolates
(24 %) were concomitantly resistant to tetracycline, erythro-
mycin and clindamycin (Table 1). Resistant isolates had three
different PFGE patterns (A1, A2, A3) and they all harboured
the tet(O) and erm(B) genes; other tetracycline and macrolide
resistance genes, such as tet(M), tet(40), tet(L), tet(K), tet(W)
and mef(A) were not detected. None of the isolates was posi-
tive for the ermB-tetO linkage, characteristic for the
ICESsuBM407-2 [18]. Additionally, one isolate was positive
for the lsa(E) gene and the lnu(B) gene (in both cases verified
by sequencing). As demonstrated by PCR with primers spe-
cific for the two genes, lnu(B) was located directly down-
stream of lsa(E). All 21 isolates tested negative for the pres-
ence of transposon- and plasmid-specific genes, such as
intTn916, rep1, rep2, reppBM407 and relBE; a single resistant
isolate carried the ω-ε-ζ genes of TAS. The repA gene, char-
acteristic for ICESsuSC84 and ICESsuBM407-2, occurred exclu-
sively among five resistant isolates. All isolates were positive
for the comR and comX competence genes.
Discussion
Streptococcus suis is currently emerging as an important zoo-
notic pathogen in humans, especially in some regions of the
world. The aim of our study was to provide extensive charac-
terisation of isolates of this pathogen observed in Poland since
2000. Most of the patients affected by S. suis infection were
male and middle-aged; the patient’s profession is not routinely
reported to the NRCBM, but for two patients (a farmer and a
butcher), infection was very likely caused by occupational
exposure. Misidentification is considered a common cause
for the underestimation of rates of invasive infections caused
by S. suis [2]. In our study, isolates were reported to the ref-
erence laboratory as S. suis in only 11 cases (52 %); five
isolates were reported as Streptococcus spp. and two as
Streptococcus bovis, while the remaining three isolates were
misidentified as S. agalactiae, Streptococcus anginosus and
Streptococcus sanguinis.
On the basis of the serotype-specific PCR results and epi-
demiological information reported so far [41], all studied iso-
lates were determined as serotype 2, which is most frequently
observed in infections of humans [2, 41]. It has to be noted,
however, that DNA-based methods do not allow discerning
between serotypes 2 and 1/2, whose cps loci do not differ by
any serotype-specific genes and whose sequences are almost
identical [43]. Although strains of serotype 1/2 have not been
reported from human infections [41], the presence of isolates
with this serotype cannot be completely excluded in our col-
lection due to the limitations of the method used. MLST uni-
formly identified all isolates as ST1. Isolates of this ST and its
variants have been reported from human invasive infections
worldwide, although STs from other clonal complexes have
also been described, including, for example, ST20 in France
and the Netherlands, STs 25 and 28 in Thailand and Japan,
and ST25 in the United States (summarised in [41]). As shown
recently in a Dutch study [44], the diversity of human isolates
of S. suis appears generally much more limited in comparison
to strains circulating in pigs in the same geographic area and a
similar time span, and the vast majority of STs and serotypes
found in pigs, a natural reservoir of this pathogen, have never
been isolated from humans [41]. Our PFGE analysis discerned
four different profiles and we additionally applied MLVA,
which was suggested as a typing method allowing additional
discrimination of strains, e.g. during an outbreak [26]. In the
case of ST1, variability was reported only for the TR9 locus,
which was selected for in our analyses. These yielded 17 var-
iants with an even bigger range of the repeat number (8–72)
than observed in the original study [26]. Such high diversity of
a presumably quickly evolving typing marker is consistent
with the sporadic character of all cases of human infections
from which our isolates were obtained.
Biofilms play an important role in reducing bacterial sus-
ceptibility to antimicrobials and clearance by the host immune
system. Formation of biofilm by S. suis required the presence
of fibrinogen in the culture medium [24], as also seen in our
study.We observed various levels of biofilm formation among
our isolates, which was also reported by others for SS2 [45].
Some of our isolates lacked detectable DNase activity, in con-
trast to the findings of Haas and co-workers, who reported all
ten ST1 strains in their study as DNase-positive [17]. Almost
all isolates demonstrated haemolytic phenotype, associated
with the presence of the sly gene. Sly, a pore-forming toxin,
plays an important role in the pathogenesis of S. suis infection
[46] and several studies reported all ST1 human isolates as
positive for sly [47–50], in contrast to representatives of other
clonal groups found in humans [49] and isolates from
non-invasive infections and carriage in pigs [30, 34]. This
gene is typically well conserved in S. suis and loss of
haemolytic activity is usually due to the replacement of sly
by orfC encoding a product of unknown function [30]; how-
ever, one of the isolates in the current study lacked both sly
Eur J Clin Microbiol Infect Dis
and orfC. Such isolates were also observed by others [48] and
our searches of the available genomic sequences of S. suis in
the GenBank (as of 29th January 2016) revealed that a single
strain YS56 (GenBank accession number ALMY01000022)
was negative for these two genes in the corresponding posi-
tion of its genome.
The isolates analysed in our study carried genes of several
virulence-associated factors other than sly, such as mrp, epf,
fbpS, eno, sao and ofs. The basic variant of the epf gene ap-
pears to be, similarly to sly, a marker specific for invasive ST1
strains [47–50], whilemrp, fbpS, eno, sao and ofs appear to be
much more common in the whole S. suis population [29, 32,
47–51]. In agreement with other observations, our analysis
also revealed variation in the genes of some of these
virulence-associated determinants, including novel alleles of
mrp, sao and ofs. Themrp gene with a single 411-bp repeat in
its 3′ part, most common among our isolates, is typical for
ST1; a shorter version, mrpS, present in one isolate, was also
observed for this ST [49]. Larger variants ofmrp occur among
representatives of other CCs associated with serotype 2, such
as ST29 [49] and other serotypes [34]. Three isolates from our
collection harboured new indel mutations in mrp, preventing
the full-length Mrp protein synthesis. Such mutations are rel-
atively common in S. suis [33], and isolates positive for the
gene but negative for the protein expression are frequently
observed [33, 34, 50]. Variability in the mrp gene may be
associated with a selective pressure from the immunological
system of the host [34]. The sao-M (seven repeats), observed
in our study for almost all isolates, is the most common variant
among various serotypes of S. suis [32], and type 1 ofs char-
acteristic for all but one isolate is typical for ST1 [16]. In our
study, all isolates belonged to the genotype A of pili and
harboured the characteristic frame-shift mutation in sbp2. At
least four different pili loci exist in S. suis, and the combina-
tion of presence/absence of particular genes allowed
distinguishing 12 genotypes, with genotype A being charac-
teristic for ST1 isolates from human infections and diseased
pigs [15]. We did not detect sequences specific for the 89K
candidate PAI, found in highly virulent strains involved in two
outbreaks in China and, as yet, not observed anywhere else
[31]. In summary, inclusion of all the study isolates into ST1
and SS2, together with the observed high number of
established and putative virulence factors, are consistent with
the features of a specific genetic cluster of S. suis, associated
with human meningitis [52], described also as the epidemic
and highly virulent (E/HV) group, showing resistance to
phagocytosis in vivo, thus allowing bacteria persistence at
high concentrations in the animal mouse model, a
pre-requisite for the development of an inflammatory reaction
in the host [53].
Importantly, the investigated isolates of S. suis from our
collection retained susceptibility to agents recommended in
Poland for empirical therapy of community-acquired bacterial
meningitis in adults, such as cefotaxime and vancomycin
(http://www.koroun.edu.pl, accessed 17th December 2015).
As yet, no resistance to these compounds has been reported
for S. suis isolated from humans [54–56]. We observed
concomitant resistance to erythromycin and tetracycline for
24 % of isolates. Resistance to tetracycline appears to be
common, or even very common, in S. suis from human
infections, reaching 100 % among 114 strains of ST7 in
China [54], 100 % among 33 isolates in Hong Kong [55]
and 89 % among 175 isolates in Vietnam, with a clear
increase over the period 1997–2008 [56]. Resistance rates to
erythromycin were 21 % and 22 % in Hong Kong and
Vietnam, respectively [55, 56], similar to our observations.
The acquisition of resistance determinants by S. suis occurs
chiefly in its animal host under the selective pressure exerted
by the use of antimicrobial agents in animal production. In
Poland, according to the European Surveillance of
Veterinary Antimicrobial Consumption (ESVAC) report for
2011, the sales of lincosamides, macrolides and tetracyclines
for food-producing animals amounted to 4.1, 25.6 and 179.6
tonnes, respectively [57], and resistance to erythromycin and
tetracycline among pig isolates reached 31 % and 64 %, re-
spectively, in 2004 [58]. In our collection, isolates resistant to
tetracycline and erythromycin/clindamycin carried the tet(O)
and erm(B) genes. The presence of tet(O) was reported for a
small number of human isolates from Europe and North
America [54]. The tet(M) gene, associated with Tn916, was
the most widespread determinant of tetracycline resistance in
human S. suis in China and Vietnam [54, 56]. In Vietnam, tet
(O) was the second most common gene responsible for tetra-
cycline resistance; tet(L) and tet(W)were also observed in that
study [56]. The erm(B) gene was present in 95 % of
erythromycin-resistant human S. suis in Vietnam [56], while
in Hong Kong, most of the isolates carried mef(A) [55]. Thus,
there are obvious differences in the local epidemiology of
tetracycline and erythromycin resistance genes among human
S. suis. Additionally, one of the resistant isolates in our col-
lection carried the lsa(E) and lnu(B) genes. The lsa(E) gene
encodes an ABC transporter that confers resistance to
lincosamides, streptogramin A and pleuromutilins (LSAP
phenotype) by efflux of the drugs from the bacterial cell
[59] , whi l e l nu (B) ( fo rmer ly l i nB ) inac t iva tes
lincosamides by adenylation [60]. These two genes are
found in several Gram(+) bacteria, e.g. E. faecalis
(AF408195), the C2944 strain of S. aureus, the SGB76
strain of S. agalactiae, the pDX5 plasmid of E. faecium
and the Ery-11 strain of the pig pathogen Erysipelothrix
rhusiopathiae [61–64], but, to our knowledge, have not
yet been reported in S. suis. Our search of genomic se-
quences of 375 pig and human isolates of S. suis [65],
deposited at the European Nucleotide Archive (http://
www.ebi.ac.uk/ena, accessed 2nd February 2016),
revealed the presence of lsa(E) and lnu(B) in four pig
Eur J Clin Microbiol Infect Dis
isolates, associated with serotype 2 from Vietnam and in
two pig isolates of serotypes 7 and 14 from the United
Kingdom, suggesting independent acquisition of these
resistance genes by different clones in various parts of
the world. The macrolide, lincosamide and tetracycline
resistance determinants detected among isolates from our
collection were likely carried by S. suis-specific ICEs [18]
, consistent with the concomitant presence of their repA
gene and absence of genes characteristic for other mobile
elements, such as Tn916 and broad-host plasmids.
In conclusion, we performed a detailed phenotypic and
genotypic analysis of S. suis isolates obtained in Poland
from invasive human infections. While all these isolates
belonged to a single clonal complex associated with con-
siderable morbidity and mortality in humans worldwide,
diversification of this complex was observed, including
the presence of novel variants of virulence determinants
and the acquisition of antimicrobial resistance genes. The
human invasive S. suis infections in Poland very likely
remain underestimated, considering the fact that, in
2012, the number of professionally active farmers
amounted to 2.1 million and pig livestock exceeded 10
million heads (http://www.stat.gov.pl, accessed 17th
December 2015), which indicates an existence of a
significant at-risk human population and a need for im-
proved surveillance of invasive human infections, caused
by this pathogen in our country.
Acknowledgements We thank all Polish microbiologists who sent
S. suis isolates to our laboratory and Stephen Murchan for the critical
reading of the manuscript. This publication made use of the
Streptococcus suis MLST website (http://ssuis.mlst.net/) hosted at
Imperial College of the University of Oxford and funded by the
Wellcome Trust. Parts of this study were presented at the 24th
European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID), 10–13th May 2014, Barcelona, Spain.
Compliance with ethical standards Isolates were obtained as part of
the routine activity of the NRCBM and were analysed anonymously in a
retrospective manner. Ethical approval and informed consent were, thus,
not required.
Conflict of interest The authors declare that they have no conflict of
interest.
Funding This work was supported by the grant NZ2/01945 from
Narodowe Centrum Nauki (NCN), Poland.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Staats JJ, Feder I, Okwumabua O, Chengappa MM (1997)
Streptococcus suis: past and present. Vet Res Commun 21:381–407
2. Huong VT, Ha N, Huy NT et al (2014) Epidemiology, clinical
manifestations, and outcomes of Streptococcus suis infection in
humans. Emerg Infect Dis 20:1105–1114. doi:10.3201/eid2007.
131594
3. Ferrando ML, de Greeff A, van Rooijen WJ et al (2015) Host–
pathogen interaction at the intestinal mucosa correlates with zoo-
notic potential of Streptococcus suis. J Infect Dis 212:95–105. doi:
10.1093/infdis/jiu813
4. Mai NT, Hoa NT, Nga TV et al (2008) Streptococcus suis menin-
gitis in adults in Vietnam. Clin Infect Dis 46:659–667. doi:10.1086/
527385
5. le Tien HT, Nishibori T, Nishitani Y, Nomoto R, Osawa R (2013)
Reappraisal of the taxonomy of Streptococcus suis serotypes 20,
22, 26, and 33 based on DNA–DNA homology and sodA and recN
phylogenies. Vet Microbiol 162:842–849. doi:10.1016/j.vetmic.
2012.11.001
6. Ngo TH, Tran TB, Tran TT et al (2011) Slaughterhouse pigs are a
major reservoir of Streptococcus suis serotype 2 capable of causing
human infection in southern Vietnam. PLoS One 6:e17943. doi:10.
1371/journal.pone.0017943
7. Yu H, Jing H, Chen Z et al (2006) Human Streptococcus suis out-
break, Sichuan, China. Emerg Infect Dis 12:914–920
8. Chen C, Tang J, Dong W et al (2007) A glimpse of streptococcal
toxic shock syndrome from comparative genomics of S. suis 2
Chinese isolates. PLoS One 2:e315
9. Li M, Wang C, Feng Y et al (2008) SalK/SalR, a two-component
signal transduction system, is essential for full virulence of highly
invasive Streptococcus suis serotype 2. PLoS One 3:e2080. doi:10.
1371/journal.pone.0002080
10. Zhao Y, Liu G, Li S et al (2011) Role of a type IV-like secretion
system of Streptococcus suis 2 in the development of streptococcal
toxic shock syndrome. J Infect Dis 204:274–281. doi:10.1093/
infdis/jir261
11. Zheng JX, Li Y, Zhang H, Fan HJ, Lu CP (2013) Identification and
characterization of a novel hemolysis-related gene in Streptococcus
suis serotype 2. PLoS One 8:e74674. doi:10.1371/journal.pone.
0074674
12. King SJ, Leigh JA, Heath PJ, Luque I, Tarradas C, Dowson CG,
Whatmore AM (2002) Development of a multilocus sequence typ-
ing scheme for the pig pathogen Streptococcus suis: identification
of virulent clones and potential capsular serotype exchange. J Clin
Microbiol 40:3671–3680
13. Feng Y, Zhang H, Ma Y, Gao GF (2010) Uncovering newly emerg-
ing variants of Streptococcus suis, an important zoonotic agent.
Trends Microbiol 18:124–131. doi:10.1016/j.tim.2009.12.003
14. Fittipaldi N, Segura M, Grenier D, Gottschalk M (2012) Virulence
factors involved in the pathogenesis of the infection caused by the
swine pathogen and zoonotic agent Streptococcus suis. Future
Microbiol 7:259–279. doi:10.2217/fmb.11.149
15. Takamatsu D, Nishino H, Ishiji T et al (2009) Genetic organization
and preferential distribution of putative pilus gene clusters in
Streptococcus suis. Vet Microbiol 138:132–139. doi:10.1016/j.
vetmic.2009.02.013
16. Takamatsu D, Osaki M, Tharavichitkul P, Takai S, Sekizaki T
(2008) Allelic variation and prevalence of serum opacity factor
among the Streptococcus suis population. J Med Microbiol 57:
488–494. doi:10.1099/jmm.0.47755-0
17. Haas B, Bonifait L, Vaillancourt K, Charette SJ, Gottschalk M,
Grenier D (2014) Characterization of DNase activity and gene in
Streptococcus suis and evidence for a role as virulence factor. BMC
Res Notes 7:424. doi:10.1186/1756-0500-7-424
Eur J Clin Microbiol Infect Dis
18. Holden MT, Hauser H, Sanders M et al (2009) Rapid evolution of
virulence and drug resistance in the emerging zoonotic pathogen
Streptococcus suis. PLoS One 4:e6072
19. Cantin M, Harel J, Higgins R, Gottschalk M (1992) Antimicrobial
resistance patterns and plasmid profiles of Streptococcus suis iso-
lates. J Vet Diagn Invest 4:170–174
20. Zaccaria E, van Baarlen P, de Greeff A, Morrison DA, Smith H,
Wells JM (2014) Control of competence for DNA transformation in
Streptococcus suis by genetically transferable pherotypes. PLoS
One 9:e99394. doi:10.1371/journal.pone.0099394
21. Zalas-Wiecek P, Michalska A, Grabczewska E, Olczak A,
Pawlowska M, Gospodarek E (2013) Human meningitis caused
by Streptococcus suis. J Med Microbiol 62:483–485. doi:10.
1099/jmm.0.046599-0
22. Clinical and Laboratory Standards Institute (CLSI) (2010)
Performance standards for antimicrobial susceptibility testing;
Twentieth informational supplement. CLSI document M100-S20.
CLSI, Wayne, PA
23. European Committee on Antimicrobial Susceptibility Testing
(EUCAST) (2014) Breakpoint tables for interpretation of MICs
and zone diameters. Version 4.0. Available online at: http://www.
eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_
tables/Breakpoint_table_v_4.0.pdf. Accessed 17th December 2015
24. Bonifait L, Grignon L, Grenier D (2008) Fibrinogen induces bio-
film formation by Streptococcus suis and enhances its antibiotic
resistance. Appl Environ Microbiol 74:4969–4972. doi:10.1128/
AEM.00558-08
25. Berthelot-Hérault F, Marois C, Gottschalk M, Kobisch M (2002)
Genetic diversity of Streptococcus suis strains isolated from pigs
and humans as revealed by pulsed-field gel electrophoresis. J Clin
Microbiol 40:615–619
26. Li W, Ye C, Jing H et al (2010) Streptococcus suis outbreak inves-
tigation using multiple-locus variable tandem repeat number anal-
ysis. Microbiol Immunol 54:380–388. doi:10.1111/j.1348-0421.
2010.00228.x
27. Zhu Y, Tan Z, Zhu L et al (2008) Streptococcus suis serotype 2
caused streptococcal toxic shock syndrome (STSS) in a patient. J
Nanjing Med Univ 22:313–316
28. Wisselink HJ, Reek FH, Vecht U, Stockhofe-Zurwieden N, Smits
MA, Smith HE (1999) Detection of virulent strains of
Streptococcus suis type 2 and highly virulent strains of
Streptococcus suis type 1 in tonsillar specimens of pigs by PCR.
Vet Microbiol 67:143–157
29. Esgleas M, Li Y, HancockMA, Harel J, Dubreuil JD, GottschalkM
(2008) Isolation and characterization of alpha-enolase, a novel
fibronectin-binding protein from Streptococcus suis. Microbiology
154:2668–2679. doi:10.1099/mic.0.2008/017145-0
30. King SJ, Heath PJ, Luque I, Tarradas C, Dowson CG, Whatmore
AM (2001) Distribution and genetic diversity of suilysin in
Streptococcus suis isolated from different diseases of pigs and char-
acterization of the genetic basis of suilysin absence. Infect Immun
69:7572–7582
31. Schmid S, O’Connor M, Okwumabua O (2011) The pathogenicity
island-like DNA segment associated with Chinese outbreak strain
of Streptococcus suis serotype 2 is absent in the United States iso-
lates. Int J Mol Epidemiol Genet 2:56–60
32. Feng Y, Zheng F, Pan X et al (2007) Existence and charac-
terization of allelic variants of Sao, a newly identified sur-
face protein from Streptococcus suis. FEMS Microbiol Lett
275:80–88
33. Fittipaldi N, Fuller TE, Teel JF et al (2009) Serotype distri-
bution and production of muramidase-released protein, extra-
cellular factor and suilysin by field strains of Streptococcus
suis isolated in the United States. Vet Microbiol 139:310–
317. doi:10.1016/j.vetmic.2009.06.024
34. Silva LM, Baums CG, Rehm T et al (2006) Virulence-associated
gene profiling of Streptococcus suis isolates by PCR. Vet Microbiol
115:117–127
35. Doherty N, Trzcinski K, Pickerill P, Zawadzki P, Dowson CG
(2000) Genetic diversity of the tet(M) gene in tetracycline-
resistant clonal lineages of Streptococcus pneumoniae.
Antimicrob Agents Chemother 44:2979–2984
36. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG (2000)
Expression of resistance to tetracyclines in strains of methicillin-
resistant Staphylococcus aureus. J Antimicrob Chemother 45:763–
770
37. Aminov RI, Garrigues-Jeanjean N, Mackie RI (2001) Molecular
ecology of tetracycline resistance: development and validation of
primers for detection of tetracycline resistance genes encoding ri-
bosomal protection proteins. Appl Environ Microbiol 67:22–32.
doi:10.1128/AEM.67.1.22-32.2001
38. Sutcliffe J, Grebe T, Tait-Kamradt A,Wondrack L (1996) Detection
of erythromycin-resistant determinants by PCR. Antimicrob Agents
Chemother 40:2562–2566
39. Jensen LB, Garcia-Migura L, Valenzuela AJ, Løhr M, Hasman H,
Aarestrup FM (2010) A classification system for plasmids from
enterococci and other Gram-positive bacteria. J Microbiol
Methods 80:25–43. doi:10.1016/j.mimet.2009.10.012
40. Moritz EM, Hergenrother PJ (2007) Toxin–antitoxin systems are
ubiquitous and plasmid-encoded in vancomycin-resistant entero-
cocci. Proc Natl Acad Sci U S A 104:311–316
41. Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M
(2014) Streptococcus suis, an important pig pathogen and emerging
zoonotic agent-an update on the worldwide distribution based on
serotyping and sequence typing. Emerg Microbes Infect 3:e45. doi:
10.1038/emi.2014.45
42. Liu G, Zhang W, Lu C (2012) Complete genome sequence of
Streptococcus agalactiae GD201008-001, isolated in China from
Tilapia with meningoencephalitis. J Bacteriol 194:6653. doi:10.
1128/JB.01788-12
43. Okura M, Takamatsu D, Maruyama F et al (2013) Genetic analysis
of capsular polysaccharide synthesis gene clusters from all sero-
types of Streptococcus suis: potential mechanisms for generation
of capsular variation. Appl Environ Microbiol 79:2796–2806. doi:
10.1128/AEM.03742-12
44. Schultsz C, Jansen E, Keijzers W et al (2012) Differences in the
population structure of invasive Streptococcus suis strains isolated
from pigs and from humans in The Netherlands. PLoS One 7:
e33854. doi:10.1371/journal.pone.0033854
45. Dawei G, Liping W, Chengping L (2012) In vitro biofilm forming
potential of Streptococcus suis isolated from human and swine in
China. Braz J Microbiol 43:993–1004. doi:10.1590/S1517-
838220120003000021
46. He Z, Pian Y, Ren Z et al (2014) Increased production of suilysin
contributes to invasive infection of the Streptococcus suis strain
05ZYH33. Mol Med Rep 10:2819–2826. doi:10.3892/mmr.2014.
2586
47. Takamatsu D, Wongsawan K, Osaki M et al (2008) Streptococcus
suis in humans, Thailand. Emerg Infect Dis 14:181–183. doi:10.
3201/eid1401.070568
48. Fittipaldi N, Xu J, Lacouture S et al (2011) Lineage and virulence of
Streptococcus suis serotype 2 isolates from North America. Emerg
Infect Dis 17:2239–2244. doi:10.3201/eid1712.110609
49. Kerdsin A, Dejsirilert S, Puangpatra P et al (2011) Genotypic pro-
file of Streptococcus suis serotype 2 and clinical features of infec-
tion in humans, Thailand. Emerg Infect Dis 17:835–842. doi:10.
3201/eid1705.100754
50. de Greeff A, Wisselink HJ, de Bree FM et al (2011) Genetic diver-
sity of Streptococcus suis isolates as determined by comparative
genome hybridization. BMC Microbiol 11:161. doi:10.1186/
1471-2180-11-161
Eur J Clin Microbiol Infect Dis
51. Dong W, Ma J, Zhu Y et al (2015) Virulence genotyping and pop-
ulation analysis of Streptococcus suis serotype 2 isolates from
China. Infect Genet Evol 36:483–489. doi:10.1016/j.meegid.2015.
08.021
52. Chen C, Zhang W, Zheng H et al (2013) Minimum core genome
sequence typing of bacterial pathogens: a unified approach for clin-
ical and public health microbiology. J Clin Microbiol 51:2582–
2591. doi:10.1128/JCM.00535-13
53. Zheng H, Lan R, Zheng X et al (2014) Comparative genomic hy-
bridization identifies virulence differences in Streptococcus suis.
PLoS One 9:e87866. doi:10.1371/journal.pone.0087866
54. Ye C, Bai X, Zhang J et al (2008) Spread of Streptococcus suis
sequence type 7, China. Emerg Infect Dis 14:787–791. doi:10.
3201/eid1405.070437
55. Chu YW, Cheung TK, Chu MY et al (2009) Resistance to tetracy-
cline, erythromycin and clindamycin in Streptococcus suis serotype
2 in Hong Kong. Int J Antimicrob Agents 34:181–182. doi:10.
1016/j.ijantimicag.2009.01.007
56. Hoa NT, Chieu TT, Nghia HD et al (2011) The antimicrobial resis-
tance patterns and associated determinants in Streptococcus suis
isolated from humans in Southern Vietnam, 1997–2008. BMC
Infect Dis 11:6. doi:10.1186/1471-2334-11-6
57. European Medicines Agency (EMA) (2013) Sales of veterinary
antimicrobial agents in 25 EU/EEA countries in 2011. Third
ESVAC report. EMA/236501/2013. Available online at: http://
www.ema.europa.eu/docs/en_GB/document_library/Report/2013/
10/WC500152311.pdf. Accessed 17th December 2015
58. Hendriksen RS, Mevius DJ, Schroeter A et al (2008) Occurrence of
antimicrobial resistance among bacterial pathogens and indicator
bacteria in pigs in different European countries from year 2002–
2004: the ARBAO-II study. Acta Vet Scand 50:19. doi:10.1186/
1751-0147-50-19
59. Wendlandt S, Lozano C, Kadlec K et al (2013) The enterococcal
ABC transporter gene lsa(E) confers combined resistance to
lincosamides, pleuromutilins and streptogramin A antibiotics in
methicillin-susceptible and methicillin-resistant Staphylococcus
aureus. J Antimicrob Chemother 68:473–475. doi:10.1093/jac/
dks398
60. Bozdogan B, Berrezouga L, Kuo MS et al (1999) A new resistance
gene, l inB , conferring resistance to lincosamides by
nucleotidylation in Enterococcus faecium HM1025. Antimicrob
Agents Chemother 43:925–929
61. Lozano C, Aspiroz C, Sáenz Y et al (2012) Genetic environment
and location of the lnu(A) and lnu(B) genes in methicillin-resistant
Staphylococcus aureus and other staphylococci of animal and hu-
man origin. J Antimicrob Chemother 67:2804–2808. doi:10.1093/
jac/dks320
62. Montilla A, Zavala A, Cáceres Cáceres R et al (2014) Genetic
environment of the lnu(B) gene in a Streptococcus agalactiae clin-
ical isolate. Antimicrob Agents Chemother 58:5636–5637. doi:10.
1128/AAC.02630-14
63. Wang XM, Li XS, Wang YB et al (2015) Characterization of a
multidrug resistance plasmid from Enterococcus faecium that har-
bours a mobilized bcrABDR locus. J Antimicrob Chemother 70:
609–611. doi:10.1093/jac/dku416
64. Zhang A, Xu C, Wang H et al (2015) Presence and new
genet ic envi ronment of pleuromut i l in- l incosamide-
streptogramin A resistance gene lsa(E) in Erysipelothrix
rhusiopathiae of swine origin. Vet Microbiol 177:162–167.
doi:10.1016/j.vetmic.2015.02.014
65. Weinert LA, Chaudhuri RR, Wang J et al (2015) Genomic signa-
tures of human and animal disease in the zoonotic pathogen
Streptococcus suis. Nat Commun 6:6740. doi:10.1038/
ncomms7740
Eur J Clin Microbiol Infect Dis
